Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Islet distribution of Peptide YY and its regulatory role in primary mouse islets and immortalised rodent and human beta-cell function and survival
Dawood Khan, Srividya Vasu, R. Charlotte Moffett, et al.
Molecular and Cellular Endocrinology (2016) Vol. 436, pp. 102-113
Open Access | Times Cited: 74

Showing 26-50 of 74 citing articles:

Excitotoxicity and Overnutrition Additively Impair Metabolic Function and Identity of Pancreatic β-Cells
Anna B. Osipovich, Jennifer S. Stancill, Jean‐Philippe Cartailler, et al.
Diabetes (2020) Vol. 69, Iss. 7, pp. 1476-1491
Open Access | Times Cited: 21
Differential expression of glucagon-like peptide-2 (GLP-2) is involved in pancreatic islet cell adaptations to stress and beta-cell survival
Dawood Khan, Srividya Vasu, R. Charlotte Moffett, et al.
Peptides (2017) Vol. 95, pp. 68-75
Closed Access | Times Cited: 24
C-terminal degradation of PYY peptides in plasma abolishes effects on satiety and beta-cell function
Ryan A. Lafferty, Peter R. Flatt, Nigel Irwin
Biochemical Pharmacology (2018) Vol. 158, pp. 95-102
Open Access | Times Cited: 22
Novel Pharmaceuticals in Appetite Regulation: Exploring emerging gut peptides and their pharmacological prospects
Igor Rubinić, Marija Kurtov, Robert Likić
Pharmacology Research & Perspectives (2024) Vol. 12, Iss. 4
Open Access | Times Cited: 2
Expression of Gastrin Family Peptides in Pancreatic Islets and Their Role in β-Cell Function and Survival
Dawood Khan, Srividya Vasu, R. Charlotte Moffett, et al.
Pancreas (2018) Vol. 47, Iss. 2, pp. 190-199
Closed Access | Times Cited: 20
Benefits of Sustained Upregulated Unimolecular GLP-1 and CCK Receptor Signalling in Obesity-Diabetes
Neil Tanday, Andrew English, Ryan A. Lafferty, et al.
Frontiers in Endocrinology (2021) Vol. 12
Open Access | Times Cited: 16
Beneficial metabolic effects of recurrent periods of beta‐cell rest and stimulation using stable neuropeptide Y1 and glucagon‐like peptide‐1 receptor agonists
Neil Tanday, Ryan A. Lafferty, Peter R. Flatt, et al.
Diabetes Obesity and Metabolism (2022) Vol. 24, Iss. 12, pp. 2353-2363
Open Access | Times Cited: 11
RISING STARS: Endocrine regulation of metabolic homeostasis via the intestine and gut microbiome
Rachel K. Meyer, Frank A. Duca
Journal of Endocrinology (2023) Vol. 258, Iss. 2
Open Access | Times Cited: 6
Actions of PGLa-AM1 and its [A14K] and [A20K] analogues and their therapeutic potential as anti-diabetic agents
Bosede O. Owolabi, Vishal Musale, Opeolu O. Ojo, et al.
Biochimie (2017) Vol. 138, pp. 1-12
Open Access | Times Cited: 18
Islet neuropeptide Y receptors are functionally conserved and novel targets for the preservation of beta‐cell mass
Zara J. Franklin, Anastasia Tsakmaki, Patricia Fonseca Pedro, et al.
Diabetes Obesity and Metabolism (2017) Vol. 20, Iss. 3, pp. 599-609
Open Access | Times Cited: 18
Temporal Transcriptome Analysis Reveals Dynamic Gene Expression Patterns Driving β-Cell Maturation
Tiziana Sanavia, Chen Huang, Elisabetta Manduchi, et al.
Frontiers in Cell and Developmental Biology (2021) Vol. 9
Open Access | Times Cited: 14
Neuropeptide Y1 receptor antagonism protects β-cells and improves glycemic control in type 2 diabetes
Chieh-Hsin Yang, Danise Ann-Onda, Xuzhu Lin, et al.
Molecular Metabolism (2021) Vol. 55, pp. 101413-101413
Open Access | Times Cited: 13
Role of islet peptides in beta cell regulation and type 2 diabetes therapy
Dawood Khan, Charlotte R. Moffet, Peter R. Flatt, et al.
Peptides (2018) Vol. 100, pp. 212-218
Closed Access | Times Cited: 15
Nonclassical Islet Peptides: Pancreatic and Extrapancreatic Actions
Andrew English, Nigel Irwin
Clinical Medicine Insights Endocrinology and Diabetes (2019) Vol. 12
Open Access | Times Cited: 15
Development and characterisation of a peptidergic N-and C-terminally stabilised mammalian NPY1R agonist which protects against diabetes induction
Ryan A. Lafferty, Neil Tanday, Peter R. Flatt, et al.
Biochimica et Biophysica Acta (BBA) - General Subjects (2020) Vol. 1864, Iss. 5, pp. 129543-129543
Open Access | Times Cited: 14
Y1 receptor deficiency in β-cells leads to increased adiposity and impaired glucose metabolism
Kim Loh, Yan‐Chuan Shi, Mohammed Bensellam, et al.
Scientific Reports (2018) Vol. 8, Iss. 1
Open Access | Times Cited: 14
Short-term CFTR inhibition reduces islet area in C57BL/6 mice
Dawood Khan, R.C. Kelsey, Rashmi R Maheshwari, et al.
Scientific Reports (2019) Vol. 9, Iss. 1
Open Access | Times Cited: 13
Development and characterisation of novel, enzymatically stable oxytocin analogues with beneficial antidiabetic effects in high fat fed mice
Shruti Mohan, Andrew McCloskey, Aine McKillop, et al.
Biochimica et Biophysica Acta (BBA) - General Subjects (2020) Vol. 1865, Iss. 3, pp. 129811-129811
Open Access | Times Cited: 12
Sex-based impact of pancreatic islet stressors in GluCreERT2/Rosa26-eYFP mice
Neil Tanday, Aimee Coulter‐Parkhill, R. Charlotte Moffett, et al.
Journal of Endocrinology (2023) Vol. 259, Iss. 2
Open Access | Times Cited: 4
Peptides from Natural or Rationally Designed Sources Can Be Used in Overweight, Obesity, and Type 2 Diabetes Therapies
Mayara C. F. Gewehr, Renata Silvério, José Cesar Rosa Neto, et al.
Molecules (2020) Vol. 25, Iss. 5, pp. 1093-1093
Open Access | Times Cited: 11
NPYR modulation: Potential for the next major advance in obesity and type 2 diabetes management?
Ryan A. Lafferty, Peter R. Flatt, Nigel Irwin
Peptides (2024) Vol. 179, pp. 171256-171256
Open Access | Times Cited: 1
[P3]PP, a stable, long‐acting pancreatic polypeptide analogue, evokes weight lowering and pancreatic beta‐cell‐protective effects in obesity‐associated diabetes
Neil Tanday, Wuyun Zhu, Andrei I. Tarasov, et al.
Diabetes Obesity and Metabolism (2024) Vol. 26, Iss. 11, pp. 4945-4957
Closed Access | Times Cited: 1
Insulinotropic, glucose-lowering, and beta-cell anti-apoptotic actions of peptides related to esculentin-1a(1-21).NH2
Vishal Musale, Yasser H.A. Abdel‐Wahab, Peter R. Flatt, et al.
Amino Acids (2018) Vol. 50, Iss. 6, pp. 723-734
Closed Access | Times Cited: 10
The main participation of the enterohormone GLP-1 after bariatric surgery
Alejandra Moreno-Arciniegas, Joshua Falckenheiner-Soria, José Bancalero-De Los Reyes, et al.
Minerva Chirurgica (2019) Vol. 74, Iss. 1
Closed Access | Times Cited: 10
GLP-1 mediated improvement of the glucose tolerance in the T2DM GK rat model after massive jejunal resection
José Arturo Prada Oliveira, Alonso Camacho-Ramírez, Jesús Salas-Alvarez, et al.
Annals of Anatomy - Anatomischer Anzeiger (2019) Vol. 223, pp. 1-7
Closed Access | Times Cited: 10

Scroll to top